BIOSPAIN 2026 - ADVANCES IN NEURODEGENERATIVE DISEASES: FROM NOVEL THERAPIES TO REAL-WORLD CLINICAL VALIDATION

ADVANCES IN NEURODEGENERATIVE DISEASES: FROM NOVEL THERAPIES TO REAL-WORLD CLINICAL VALIDATION

Tracks

SPEAKER'S ROOM 1: DOROTEA BARNÉS

Wednesday, September 30, 2026

16:00 - 16:45

SPEAKERS' CORNER 1: DOROTEA BARNÉS

Overview

Sponsor: Euskadi

Details

Adolfo Lopez de Munain

Miramoon Pharma & SEED-ALS coordinator/leader

Osakidetza, IIS Biogipuzkoa, Miramoon Pharma

.

Ana Martinez Gil

CIB-CSIC

.

Antonio Oliviero

Golden Gait Biotech

.

You need to enable JavaScript to access this site.

Follow these instructions on how to enable JavaScript.

Internet Explorer

Select Tools from the top menu
Choose Internet Options
Click on the Security tab
Click on Custom Level
Scroll down until you see the section labelled Scripting
Under Active Scripting, select Enable and click OK

Google Chrome

Select the menu icon on the browser toolbar
Select Settings
Click the Show advanced settings... link then Content Settings in the Privacy section
Select Allow all sites to run JavaScript (recommended) and click Done

Safari (Mac)

Select Safari from the top menu
Choose Preferences
Choose Security
Select the checkbox next to Enable JavaScript